| Pharmaceutical active ingredients: |
| Ethinyl EstradiolNorethindrone Acetate |
| Available forms, composition and doses of Gynovlar: |
| N / A |
| Gynovlar medical category: |
| Human:Oral contraceptives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AA05 - Norethisterone and estrogenG03AB04 - Norethisterone and estrogenG03CA01 - Ethinylestradiol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bayer Schering Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Etalontin | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Parke-Davis |
| FemHRT | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Warner Chilcott |
| FemHRT 1 / 5 | Ethinyl Estradiol; Norethindrone Acetate | Galen; Warner Chilcott |
| Gynophase | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Gynovlane | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Junel | Ethinyl Estradiol; Norethindrone Acetate | Barr Laboratories |
| Junel FE | Ethinyl Estradiol; Norethindrone Acetate | Barr Laboratories |
| Loestrin | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Galen; Parke-Davis; Warner Chilcott |
| Loestrin 1.5 / 30 | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Warner Chilcott |
| Loestrin 1.5 / 30 21 Day Pak | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Warner Chilcott |